Insulin-like growth factor-1 levels in children with Beta-thalassemia minor

Area of Science:

• Pediatric Endocrinology
• Hematology
• Genetics

Background:

• Growth retardation is a known complication in beta-thalassemia major, attributed to factors like hemochromatosis and hormonal imbalances.
• Insulin-like growth factor-1 (IGF-1) axis disturbances are implicated in growth failure in beta-thalassemia major.
• The specific role of IGF-1 in beta-thalassemia minor remains less understood.

Purpose of the Study:

• To investigate and compare insulin-like growth factor-1 (IGF-1) levels in children with beta-thalassemia minor versus healthy controls.
• To explore potential shared etiologies of growth failure between beta-thalassemia minor and major.

Main Methods:

• A case-control study involving 50 children with beta-thalassemia minor and 50 age- and sex-matched healthy children.
• Data collection included medical history, physical examination, and measurement of IGF-1 levels.
• The study was conducted in Shiraz, Iran, in 2005.

Main Results:

• Children with beta-thalassemia minor exhibited significantly lower IGF-1 levels compared to the healthy control group (P = 0.015).
• This finding indicates a potential link between beta-thalassemia trait and impaired growth factor signaling.
• The results suggest that underlying growth failure mechanisms might be shared between beta-thalassemia minor and major.

Conclusions:

• IGF-1 levels are decreased in children with beta-thalassemia minor, similar to observations in beta-thalassemia major.
• These findings suggest that similar etiologies may contribute to growth disturbances in both conditions.
• Further research is warranted to elucidate the precise mechanisms linking beta-thalassemia trait to altered IGF-1 levels and growth patterns.